PPP2R1A and gastric cancer: Analysis using the Kaplan-Meier Plotter tool demonstrated that GC patients with high PPP2R1A expression had significantly lower 5-year OS, PFS, and PPS rates compared to those with low PPP2R1A expression (P < 0.001) (Fig. 1h–j).